| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| abt-510 | interleukin-8 | small molecule | NA | drugbank | Lymphoma[MeSHID:D008223] Neoplasms[MeSHID:D009369] melanoma[MeSHID:D008545] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
NA | investigational | unknown |
| abt-510 | fibroblast growth factor 2 | small molecule | NA | drugbank , DGIDB | Lymphoma[MeSHID:D008223] Neoplasms[MeSHID:D009369] melanoma[MeSHID:D008545] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
1.52 | investigational | unknown |
| abt-510 | hepatocyte growth factor | small molecule | NA | drugbank | Lymphoma[MeSHID:D008223] Neoplasms[MeSHID:D009369] melanoma[MeSHID:D008545] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
NA | investigational | unknown |
| abt-510 | thrombospondin-1 | NA | Clinical trial target | TTD , DGIDB | Lymphoma[MeSHID:D008223] Neoplasms[MeSHID:D009369] melanoma[MeSHID:D008545] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
1.99 | phase 2 | unknown |
| abt-510 | vascular endothelial growth factor a | small molecule | NA | drugbank | Lymphoma[MeSHID:D008223] Neoplasms[MeSHID:D009369] melanoma[MeSHID:D008545] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
NA | investigational | unknown |
| click here to return to the previous page | ||||||||